MarketCap
Facebook
X
TelegramGeschäftsbericht 2023
hinzugefügt 22.02.2024
Karuna Therapeutics ROCE 2011-2026 | KRTX
ROCE Jährlich Karuna Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -39.45 | -25.72 | -28.65 | -21.19 | -11.64 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -11.64 | -39.45 | -25.33 |
ROCE Vierteljährlich Karuna Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -32.92 | -29.46 | -37.06 | -35.8 | -45.67 | -48.7 | -38.82 | -21.16 | -26.92 | -22.81 | -21.91 | -13.99 | -16.53 | -13.3 | -11.91 | -9.37 | -1.11 | 9.7 | 21.69 | 16.39 | 16.39 | 8.12 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 21.69 | -48.7 | -16.14 |
ROCE anderer Aktien in der Pharmaeinzelhändler
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Acer Therapeutics
ACER
|
146.85 | - | 2.71 % | $ 14 M |  USA |
 |
MorphoSys AG
MOR
|
2.89 | - | 2.43 % | $ 254 M |  Germany |
 |
Adaptimmune Therapeutics plc
ADAP
|
-353.66 | - | -15.15 % | $ 60.3 M |  Britain |
 |
Adverum Biotechnologies
ADVM
|
-196.79 | - | - | $ 86.2 M | USA |
 |
ANI Pharmaceuticals
ANIP
|
0.14 | $ 80.34 | - | $ 1.55 B | USA |
 |
Acasti Pharma
ACST
|
-25.04 | - | 4.01 % | $ 150 M |  Canada |
 |
Applied Genetic Technologies Corporation
AGTC
|
-60.13 | - | - | $ 26.5 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
17.36 | - | - | $ 40.3 B | USA |
 |
Adagene
ADAG
|
-46.22 | $ 2.67 | - | $ 150 M |  China |
 |
Biophytis SA
BPTS
|
-325.06 | - | -13.47 % | $ 169 M |  France |
 |
AlloVir
ALVR
|
-57.76 | - | 4.14 % | $ 49.1 M | USA |
 |
Midatech Pharma plc
MTP
|
-337.43 | - | -18.52 % | $ 27.3 M | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-61.36 | - | -1.52 % | $ 24.7 M | USA |
 |
BioNTech SE
BNTX
|
-4.81 | $ 110.34 | - | $ 27.2 B | Germany |
 |
Ampio Pharmaceuticals
AMPE
|
-75.24 | - | -11.43 % | $ 502 K | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-104.38 | $ 3.57 | - | $ 8.59 B |  Australia |
 |
Applied Molecular Transport
AMTI
|
-209.11 | - | - | $ 10.1 M | USA |
 |
ARCA biopharma
ABIO
|
-23.06 | - | 1052.0 % | $ 415 M | USA |
 |
Cabaletta Bio
CABA
|
-31.61 | $ 2.44 | - | $ 2.85 M | USA |
 |
Acorda Therapeutics
ACOR
|
167.74 | - | -24.86 % | $ 820 K | USA |
 |
Compugen Ltd.
CGEN
|
-15.7 | $ 1.71 | - | $ 153 M |  Israel |
 |
Akero Therapeutics
AKRO
|
-38.05 | - | - | $ 3.67 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-40.28 | - | - | $ 1.01 B | USA |
 |
Akebia Therapeutics
AKBA
|
151.24 | $ 1.5 | - | $ 281 M | USA |
 |
Aptose Biosciences
APTO
|
-46.69 | - | -45.71 % | $ 1.2 M | Canada |
 |
Albireo Pharma
ALBO
|
-70.32 | - | -0.23 % | $ 916 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
15.18 | - | - | - |  Russia |
 |
Ascendis Pharma A/S
ASND
|
-45.89 | $ 222.03 | - | $ 5 B |  Danmark |
 |
Allena Pharmaceuticals
ALNA
|
-252.54 | - | 3.16 % | $ 1.9 M | USA |
 |
Aptinyx
APTX
|
-163.42 | - | -39.0 % | $ 4.57 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
20.15 | $ 41.31 | - | $ 4.26 B | USA |
 |
Aravive
ARAV
|
-664.7 | - | -13.39 % | $ 1.45 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
-92.73 | - | -6.81 % | $ 3.04 B | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
26.82 | $ 24.45 | - | $ 2.9 B | USA |
 |
CRISPR Therapeutics AG
CRSP
|
-24.15 | $ 49.7 | - | $ 4.19 B |  Schweiz |
 |
Burford Capital Limited
BUR
|
14.24 | $ 8.97 | - | $ 1.44 B | Britain |
 |
Aridis Pharmaceuticals
ARDS
|
123.77 | - | 17.91 % | $ 11.1 M | USA |
|
Champions Oncology
CSBR
|
120.71 | $ 6.55 | - | $ 89.5 M | USA |
 |
Aeterna Zentaris
AEZS
|
-29.95 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
-180.78 | - | -10.17 % | $ 12.2 K | USA |
 |
Athira Pharma
ATHA
|
-225.02 | - | - | $ 269 M | USA |
 |
Athersys
ATHX
|
-531.85 | - | 3.77 % | $ 22.4 M | USA |
 |
Akouos
AKUS
|
-37.16 | - | 0.23 % | $ 488 M | USA |
 |
Avenue Therapeutics
ATXI
|
-403.4 | - | -52.27 % | $ 4.45 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-115.03 | $ 4.22 | - | $ 9.18 B | Israel |
 |
Autolus Therapeutics plc
AUTL
|
-161.2 | $ 1.46 | - | $ 373 M | Britain |
 |
Amneal Pharmaceuticals
AMRX
|
10.81 | $ 14.52 | - | $ 4.49 B | USA |
 |
AIkido Pharma
AIKI
|
-28.92 | - | 1.93 % | $ 17.4 M | USA |